Providing a Clinical Update of an EGFR Targeted ADC MRG003
Time: 11:45 am
day: Track C - Day 1 - AM
Details:
- Review the ADC landscape in China
- Investigate potent anti-tumour activity in preclinical studies
- Demonstrate manageable safety and promising efficacy in early phase clinical studies
